The new devices, known as non-scaling fixed field alternating gradient accelerators – or ns-FFAG accelerators for short – will be smaller, simpler and significantly cheaper than their synchrotron and cyclotron counterparts. It is therefore expected that they will have a major impact as next generation hospital-based clinical accelerators for proton and carbon ion beam treatment of cancer.
Although no ns-FFAG accelerator has ever been constructed, BASROC believes that its research project, entitled CONFORM, will move rapidly from conceptual design to construction of a model electron accelerator (EMMA) which will be located at the CCLRC’s Daresbury Laboratory. The experience gained in the development and operation of EMMA will inform the design and eventual construction of a prototype proton/carbon ion ns-FFAG accelerator for medical applications (PAMELA).
In addition, an extensive parallel R&D programme will evaluate the potential of ns-FFAG accelerators as proton drivers for applications in scientific and technological fields as diverse as energy and environment (eg accelerator driven sub critical reactors, waste transmutation), materials research (eg advanced neutron and muon sources for studies of the structure and dynamics of materials), and fundamental physics (eg the neutrino factory).Professor Roger Barlow of Manchester University, Project Leader of CONFORM, says
Professor Bleddyn Jones, Consultant in Clinical Oncology & Applied Radiobiology University Hospital Birmingham comments “I anticipate that the flexibility and cost-effectiveness of the ns-FFAG accelerators will ultimately make particle radiotherapy more accessible within the UK, with considerable benefits in the reduction of radiation side effects, improved quality of life and prospects of cure in a wide variety of cancers.”
Professor Bob Cywinski from the University of Leeds comments “CONFORM will revolutionise accelerator science. We can envisage powerful but compact accelerators that are fully optimised for a single application. This is a significant change from conventional philosophy in which single large accelerators are generally built for several applications – a situation in which everyone compromises.”
Dr David Wilcox of the High Power RF Faraday Partnership and Chairman of the BASROC Board, says “CONFORM will provide a real focus for advanced accelerator technology and manufacturing in the UK. The resulting development of industrial expertise will enable the UK to secure a competitive edge in the provision of accelerator components for major international projects.”
CONFORM funding will commence in March 2007 and the new accelerator should start operation within 3 years.
Professor Roger Barlow | alfa
A Dream for the Future: “Flying with Green Fuel"
25.07.2018 | Universität Bremen
Investigating cell membranes: researchers develop a substance mimicking a vital membrane component
25.05.2018 | Westfälische Wilhelms-Universität Münster
Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur
What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...
08.08.2018 | Event News
27.07.2018 | Event News
25.07.2018 | Event News
15.08.2018 | Physics and Astronomy
15.08.2018 | Earth Sciences
15.08.2018 | Physics and Astronomy